ATE399565T1 - Zusammensetzungen für die schnelle und nicht- irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung - Google Patents

Zusammensetzungen für die schnelle und nicht- irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung

Info

Publication number
ATE399565T1
ATE399565T1 AT99933731T AT99933731T ATE399565T1 AT E399565 T1 ATE399565 T1 AT E399565T1 AT 99933731 T AT99933731 T AT 99933731T AT 99933731 T AT99933731 T AT 99933731T AT E399565 T1 ATE399565 T1 AT E399565T1
Authority
AT
Austria
Prior art keywords
tds
modifiers
administration
skin
irritative
Prior art date
Application number
AT99933731T
Other languages
English (en)
Inventor
Kenneth Kirby
Berno Pettersson
Original Assignee
Transdermal Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transdermal Technologies Inc filed Critical Transdermal Technologies Inc
Application granted granted Critical
Publication of ATE399565T1 publication Critical patent/ATE399565T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99933731T 1998-07-07 1999-07-07 Zusammensetzungen für die schnelle und nicht- irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung ATE399565T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9191098P 1998-07-07 1998-07-07

Publications (1)

Publication Number Publication Date
ATE399565T1 true ATE399565T1 (de) 2008-07-15

Family

ID=22230257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933731T ATE399565T1 (de) 1998-07-07 1999-07-07 Zusammensetzungen für die schnelle und nicht- irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung

Country Status (12)

Country Link
US (3) US6444234B1 (de)
EP (1) EP1094781B1 (de)
JP (1) JP2002519366A (de)
AT (1) ATE399565T1 (de)
AU (1) AU4972599A (de)
CA (1) CA2336682C (de)
DE (1) DE69939019D1 (de)
DK (1) DK1094781T3 (de)
ES (1) ES2310042T3 (de)
MX (1) MXPA00012844A (de)
PT (1) PT1094781E (de)
WO (1) WO2000001351A1 (de)

Families Citing this family (184)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US6576660B1 (en) * 1997-10-31 2003-06-10 Arch Development Corporation Methods and compositions for regulation of 5-α-reductase activity
US6946144B1 (en) * 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US7220427B2 (en) * 1998-07-08 2007-05-22 Oryxe Mixture for transdermal delivery of low and high molecular weight compounds
US7396526B1 (en) 1998-11-12 2008-07-08 Johnson & Johnson Consumer Companies, Inc. Skin care composition
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
DE10009424A1 (de) * 2000-02-28 2001-09-06 Henkel Kgaa Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung
US20060121103A1 (en) * 2000-05-11 2006-06-08 Kenneth Kirby Transdermal delivery system
FR2811566B1 (fr) * 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et une vitamine
FR2811562B1 (fr) * 2000-07-13 2003-03-07 Oreal Composition, notamment cosmetique, renfermant la dhea et un isoflavonoide
AR030312A1 (es) 2000-08-03 2003-08-20 Antares Pharma Ipl Ag Composicion novedosa para la administracion transdermica y/o transmucosica de compuestos activos, que asegura adecuados niveles terapeuticos
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
FR2812873B1 (fr) 2000-08-11 2003-08-01 Barry Callebaut France Procede de production de polyphenols a partir de feves de cacao
EP1180331B1 (de) * 2000-08-16 2008-07-09 Unilever N.V. Mischungen von Isoflavonen und Flavonen
DE60134702D1 (de) 2000-08-16 2008-08-21 Unilever Nv Mischungen von Isoflavonen und Flavonen
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
FR2815858B1 (fr) * 2000-10-26 2003-12-12 Oreal Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et un agent susceptible d'inhiber l'irritation d'origine neurogene
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
JP2004513183A (ja) * 2000-11-14 2004-04-30 バイタル　ヘルス　サイエンシズ　プロプライアタリー　リミティド リン酸誘導体の複合体
FR2818148B1 (fr) * 2000-12-15 2005-06-24 Oreal Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
FR2818135B1 (fr) 2000-12-15 2003-02-14 Oreal Composition, notamment cosmetique, renfermant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un carotenoide
US6607735B2 (en) 2000-12-21 2003-08-19 Johnson & Johnson Consumer Companies, Inc. Method for reducing the appearance of dark circles under the eyes
NL1017333C2 (nl) * 2001-02-12 2002-08-13 Gent Natural Products Van Cosmetisch resp. farmaceutisch preparaat.
US6589591B1 (en) * 2001-07-10 2003-07-08 Baylor College Of Medicine Method for treating medical devices using glycerol and an antimicrobial agent
CN1547475B (zh) * 2001-07-27 2010-12-15 生命健康科学有限公司 含电子转移试剂的磷酸酯衍生物的皮肤制剂
WO2003015605A2 (en) * 2001-08-20 2003-02-27 University Of Virginia Patent Foundation Use of s-nitrosothiol signaling to treat disordered control of breathing
US8795716B2 (en) 2001-10-01 2014-08-05 The Procter & Gamble Company Skin care compositions on a thin sanitary napkin
CA2466536C (en) * 2001-12-13 2012-02-07 Vital Health Sciences Pty Ltd Transdermal transport of compounds
WO2003077860A2 (en) * 2002-03-13 2003-09-25 Biophysica, Inc. BOSWELLIN COMPOSITIONS ENHANCED WITH 3-β-ACETYL-11-KETO-β-BOSWELLIC ACID (“AKBA”), INDUSTRIAL MANUFACTURE AND THEIR USES
ATE385193T1 (de) 2002-03-20 2008-02-15 Mannkind Corp Inhalationsgerät
US7235249B2 (en) 2002-03-28 2007-06-26 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions
DE10228680A1 (de) * 2002-06-27 2004-01-22 Holden Development Limited, Tortola Grundlage für transdermale Formulierungen (PTF)
US7099713B2 (en) 2002-06-28 2006-08-29 Battelle Memorial Institute Skin conduction and transport systems
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US20040062794A1 (en) * 2002-09-30 2004-04-01 Lee Shulman 17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
US9035123B2 (en) 2002-10-01 2015-05-19 The Procter & Gamble Company Absorbent article having a lotioned topsheet
CA2508166A1 (en) * 2002-12-06 2004-06-24 David Claxton Compositions and methods related to lipid:emodin formulations
EP1589964B1 (de) * 2003-01-17 2011-11-23 Vital Health Sciences Pty Ltd. Verbindungen mit proliferationshemmenden eigenschaften
US20060141443A1 (en) * 2003-01-21 2006-06-29 Gyory J R Apparatus and method for transcellular testing
ES2535045T3 (es) 2003-04-10 2015-05-04 Vanderbilt Royalty Sub L.P. Usos y composiciones para administración de capsaicina
US7052715B2 (en) * 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
FR2855753B1 (fr) * 2003-06-03 2007-09-14 Dermo Cosmologie Lab De Composition a base de diosgenine applicable par voie topique
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
NZ546106A (en) 2003-10-10 2008-10-31 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US6998109B1 (en) 2004-01-07 2006-02-14 Pearson Research & Development Limited Emu-based formulations with lidocaine for wound treatment by inhibiting microbial activity
US7585850B2 (en) * 2004-02-10 2009-09-08 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
US20050271597A1 (en) * 2004-02-13 2005-12-08 Keith Alec D Prostate hypertrophy treatment composition and method
EP1732577B1 (de) * 2004-02-23 2013-04-10 Strategic Science & Technologies, LLC Topische verabreichung von l-arginin zur verbesserung des aussehens von körper und haut
EP1720551B9 (de) * 2004-03-03 2011-09-21 Vital Health Sciences Pty Ltd. Alkaloid-formulierungen
CA2561496A1 (en) * 2004-04-02 2005-10-20 Baylor College Of Medicine Novel modification of medical prostheses
US20050226827A1 (en) * 2004-04-09 2005-10-13 Thienna Ho Skin lightening composition
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
ES2429443T3 (es) * 2004-04-19 2013-11-14 Strategic Science & Technologies, Llc Suministro transdérmico de sustancias beneficiosas efectuado mediante un entorno de fuerza iónica elevada
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US20050272700A1 (en) * 2004-05-10 2005-12-08 Servet Buyuktimkin Topical treatment and prevention of human papilloma virus (HPV) infection
BRPI0514263B8 (pt) 2004-08-20 2021-05-25 Mannkind Corp método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina n-protegida
CN104436170B (zh) 2004-08-23 2018-02-23 曼金德公司 用于药物输送的二酮哌嗪盐
EP1812034A4 (de) 2004-10-08 2009-07-29 Clinuvel Pharmaceuticals Ltd Zusammensetzungen und verfahren zur induktion von melanogenese bei einer person
US9415034B2 (en) * 2005-01-05 2016-08-16 National Defense Medical Center Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
JP2008530139A (ja) * 2005-02-14 2008-08-07 ニューロジェシックス， インコーポレイテッド Ｔｒｐｖ１アゴニストを送達するための装置
WO2006092024A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
EP1858482B1 (de) 2005-03-10 2014-04-23 3M Innovative Properties Company Verfahren zur reduktion von mikrobieller kontamination
BRPI0608691A2 (pt) 2005-03-10 2010-12-07 3M Innovative Properties Company composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
WO2006105481A1 (en) * 2005-03-30 2006-10-05 Neurogesx, Inc. Low-concentration capsaicin patch and methods for treating neuropathic pain
US7563464B1 (en) 2005-04-22 2009-07-21 Bruce Eric Hudkins Treatment of mucosal membranes utilizing phytoestrogen
US7252834B2 (en) 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CA2611831C (en) * 2005-06-17 2014-09-16 Vital Health Sciences Pty Ltd. A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
AU2006290870B2 (en) * 2005-09-14 2013-02-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
EP1940346A2 (de) * 2005-09-30 2008-07-09 The Procter and Gamble Company Zusammensetzung zur regulierung des keratingewebes von säugetieren
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
US7920926B2 (en) * 2005-12-09 2011-04-05 Apsara Medical Corporation Method and apparatus for carrying out the controlled heating of tissue in the region of dermis
TW200800223A (en) * 2005-12-21 2008-01-01 Shire Pharmaceuticals Inc Transdermal delivery of meptazinol
FR2894811B1 (fr) † 2005-12-21 2008-02-22 Oreal Composition cosmetique a effet volumateur
US20070196301A1 (en) 2005-12-21 2007-08-23 L'oreal Cosmetic composition with a volumizing effect
BRPI0621081A2 (pt) * 2005-12-23 2011-11-29 Vital Health Sciences Pty Ltd método de modulação de uma ou mais citocinas imuno-reguladoras, uso de um ou mais derivados de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos, método de inibição de uma resposta inflamatória e/ou de estimulação de uma resposta anti-inflamatória, método de tratamento e/ou de profilaxia de distúbios imunológicos, distúrbios inflamatórios e/ou distúrbios proliferativos celulares, agente imuno-modulador, agente anti-inflamatório ou agente anti-cáncer e um ou mais derivado de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos
US20100112048A1 (en) * 2006-01-24 2010-05-06 Majid Fotuhi Dosage Regimen and Medicament For Reducing Risk of Onset or Progression of Dementia by Administration of Specific Vitamins and Nsaid
JP5599975B2 (ja) 2006-02-22 2014-10-01 マンカインド コーポレイション ジケトピペラジン及び活性薬剤を含有する微粒子の製剤特性の改善方法
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
AU2007273525B2 (en) * 2006-07-14 2010-09-16 National University Corporation Hokkaido University Supercooling promoting agent
CA2657636C (en) 2006-07-18 2021-11-09 Techfields Biochem Co. Ltd Positively charged water soluble prodrugs of ibuprofen with very fast skin penetration rate
EP2046727B1 (de) 2006-07-25 2014-03-12 Techfields Biochem Co. Ltd Positiv geladene, wasserlösliche prodrugs von diclofenac mit sehr schneller hautpenetrationsgeschwindigkeit
HUE028425T2 (en) 2006-08-08 2016-12-28 Techfields Biochem Co Ltd Positive charged water-soluble prodrugs of aryl and heteroarylacetic acids with very fast skin penetration rate
PL2061749T3 (pl) 2006-09-03 2018-11-30 Techfields Biochem Co. Ltd Dodatnio naładowane, rozpuszczalne w wodzie proleki acetaminofenu i związków pokrewnych o bardzo dużej szybkości przenikania przez skórę
ES2694685T3 (es) 2006-09-03 2018-12-26 Techfields Biochem Co. Ltd Profármacos solubles en agua cargados positivamente de ácidos n-arilantranílicos con muy rápida velocidad de penetración en la piel
US20080075793A1 (en) * 2006-09-21 2008-03-27 Dunshee Wayne K Antiviral compositions and methods of use
EP2084124B9 (de) * 2006-10-02 2015-07-01 Techfields Biochem Co. Ltd Positiv geladene wasserlösliche prodrugs von prostaglandinen und verwandten verbindungen mit sehr hohen hautpenetrationsraten
CN101522692A (zh) 2006-10-11 2009-09-02 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的昔康及其相关化合物的前药
US20080097557A1 (en) * 2006-10-19 2008-04-24 Apsara Medical Corporation Method and apparatus for carrying out the controlled heating of tissue in the region of dermis
EP2059125B1 (de) * 2006-10-23 2013-08-14 Ecolab Inc. Viruzide zusammensetzung
JP2010519196A (ja) * 2007-02-15 2010-06-03 ダーマ−ヤング リミテッド 経粘膜送達を高めるための組成物および方法
MX377501B (es) 2007-06-04 2025-03-10 Techfields Inc Profarmacos de nsaias con el piel y membranas con indices de penetracion muy altos y nuevos usos medicinales.
KR20100065190A (ko) 2007-09-14 2010-06-15 닛토덴코 가부시키가이샤 약물 담체
US20090155337A1 (en) * 2007-11-12 2009-06-18 Endologix, Inc. Method and agent for in-situ stabilization of vascular tissue
GB0801119D0 (en) 2008-01-22 2008-02-27 Barry Callebaut Ag Composition
WO2009105265A2 (en) * 2008-02-21 2009-08-27 Vatrix Medical, Inc. Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
EP2271214B1 (de) * 2008-03-28 2017-05-03 Particle Sciences, Inc. Pharmazeutische lösungen und verfahren zur auflösung von therapeutika
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US8499757B2 (en) 2008-06-13 2013-08-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
ES2904623T3 (es) 2008-06-20 2022-04-05 Mannkind Corp Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación
KR20130115392A (ko) * 2008-06-25 2013-10-21 이엘씨 매니지먼트 엘엘씨 피부 및 신체 외관 개선 방법 및 조성물
US20100016833A1 (en) * 2008-07-15 2010-01-21 Ogle Matthew F Devices for the Treatment of Vascular Aneurysm
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
KR101682512B1 (ko) 2008-09-15 2016-12-05 라일라 뉴트라슈티칼스 보스웰리아 세라타 추출물을 포함하는 상승적인 항-염증 조성물
US20100119605A1 (en) * 2008-11-12 2010-05-13 Isenburg Jason C Compositions for tissue stabilization
RU2630577C2 (ru) 2008-12-04 2017-09-11 Чунси ЮЙ Композиции интенсивного проникновения и их применение
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
RU2509555C2 (ru) 2009-06-12 2014-03-20 Маннкайнд Корпорейшн Микрочастицы дикетопиперазина с определенными удельными площадями поверхности
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
RU2505291C2 (ru) * 2009-06-24 2014-01-27 СТРАТЕДЖИК САЙЕНС ЭНД ТЕКНОЛОДЖИЗ, ЭлЭлСи Топическая композиция, содержащая ибупрофен
WO2010151241A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US20110218517A1 (en) * 2009-10-09 2011-09-08 Ogle Matthew F In vivo chemical stabilization of vulnerable plaque
US8444624B2 (en) 2009-10-19 2013-05-21 Vatrix Medical, Inc. Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
ES2616495T3 (es) 2009-12-16 2017-06-13 Ecolab Inc. Composición en forma de gel para la desinfección virucida de la piel de mamíferos
ES2999020T3 (en) 2010-02-05 2025-02-24 Phosphagenics Ltd Carrier comprising non-neutralised tocopheryl phosphate
KR101752635B1 (ko) * 2010-02-15 2017-07-03 라일라 뉴트라슈티칼스 신규의 보스웰리아 저-극성 고무 수지 추출물 및 이의 상승적인 조성물
PH12012501787A1 (en) 2010-03-15 2012-12-10 Laila Nutraceuticals Boswellia oil, its fractions and compositions for enhancing brain function
JP5806287B2 (ja) 2010-03-30 2015-11-10 フォスファジェニクス リミティド 経皮送達パッチ
MX359281B (es) 2010-06-21 2018-09-21 Mannkind Corp Sistema y metodos para suministrar un farmaco en polvo seco.
DK2658551T3 (da) 2010-12-29 2020-09-21 Strategic Science & Tech Llc Behandling af erektil dysfunktion og andre indikationer
WO2012092523A1 (en) 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
TR201101374A1 (tr) 2011-02-14 2012-09-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Flurbiprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
US8925726B2 (en) 2011-04-01 2015-01-06 Mannkind Corporation Blister package for pharmaceutical cartridges
TR201103183A1 (tr) 2011-04-01 2012-10-22 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Ketoprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
TR201103770A1 (tr) 2011-04-19 2012-11-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Nimesulid ve metilsülfonilmetanin topikalfarmasötik bileşimleri.
EP2709711B8 (de) 2011-05-18 2017-03-22 Vatrix Medical, Inc. Beschichtete ballons zur blutgefässstabilisierung
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2790728B1 (de) 2011-12-16 2015-08-19 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Topische pharmazeutische zusammensetzungen aus thiocolchicosid und methylsulfonylmethan
CN111012914A (zh) 2012-01-18 2020-04-17 苏州泰飞尔医药有限公司 治疗肺部疾病的高穿透力前药组合物和医药组合物
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US9283241B2 (en) 2012-07-10 2016-03-15 Clemson University Treatment to render implants resistant to diabetes
MX354163B (es) 2012-07-12 2018-02-15 Mannkind Corp Sistemas y métodos de suministro de fármaco en polvo seco.
WO2014024193A1 (en) * 2012-08-07 2014-02-13 Prodel Pharma Ltd. Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients
EP2911690A1 (de) 2012-10-26 2015-09-02 MannKind Corporation Inhalierbare influenza-impfstoffzusammensetzungen und verfahren
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP6403686B2 (ja) 2012-12-31 2018-10-10 ジェイアールエックス バイオテクノロジー，インコーポレイテッド 液体局所用医薬ナノエマルジョン製剤
SG10201708090TA (en) 2013-03-15 2017-11-29 Mannkind Corp Microcrystalline diketopiperazine compositions and methods
KR102321339B1 (ko) 2013-07-18 2021-11-02 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
CN105813690A (zh) 2013-08-21 2016-07-27 协和大学 树状聚合物-白藜芦醇复合物
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RU2016141135A (ru) 2014-07-29 2018-08-28 Терапьютиксмд, Инк. Трансдермальный крем
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US11510859B2 (en) * 2015-07-16 2022-11-29 Marinomed Biotech Ag Method for improving aqueous solubility of water-insoluble or slightly water-soluble drugs
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3337482A4 (de) * 2015-08-17 2019-03-20 Delivra Inc. Transdermale formulierungen zur abgabe von berberinverbindungen und deren verwendung in der behandlung von berberinabhängigen erkrankungen und störungen
HK1256695A1 (zh) 2015-09-17 2019-10-04 Jrx Biotechnology, Inc. 改善皮肤的水合作用或润湿作用的方法
CN108601732A (zh) 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
US10688069B2 (en) * 2016-03-31 2020-06-23 REV Pharmaceuticals LLC Sports health performance composition
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CN106349206B (zh) * 2016-08-29 2018-09-21 珀莱雅化妆品股份有限公司 一种从毛喉鞘蕊花中提取福斯高林的制备方法
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法
US10385297B2 (en) 2017-03-16 2019-08-20 The Procter & Gamble Company Methods for making encapsulate-containing product compositions
US11103465B2 (en) 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
JP2025517836A (ja) * 2022-05-26 2025-06-12 トランスダーマル デリバリー ソリューションズ コーポレーション（ディー．ビー．エー．ハイポスプレー ファーマ） 経皮インスリン製剤およびその利用法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US371683A (en) * 1887-10-18 hamlin
US3731683A (en) 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US4002775A (en) 1973-07-09 1977-01-11 Kabara Jon J Fatty acids and derivatives of antimicrobial agents
US4330551A (en) 1980-08-26 1982-05-18 Synergetics Co. Therapeutic method
DE3170312D1 (en) 1980-10-07 1985-06-05 Klaus Keplinger Extract from uncaria tomentosa (willd.) dc. for use in therapy
US5302611A (en) * 1980-10-07 1994-04-12 Klaus Keplinger Oxindole alkaloids having properties stimulating the immunologic system & preparation containing the same
US4777074A (en) * 1985-08-12 1988-10-11 Sumitomo Special Metals Co., Ltd. Grooved magnetic substrates and method for producing the same
DE3531545A1 (de) 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
US4746515A (en) 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
US4788062A (en) 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
DE3867710D1 (de) * 1987-06-01 1992-02-27 Keikichi Sugiyama Zusammensetzung zur anwendung auf haare und kopfhaut.
US4789547A (en) 1987-06-17 1988-12-06 Warner-Lambert Company Transdermal matrix system
US4820720A (en) 1987-08-24 1989-04-11 Alza Corporation Transdermal drug composition with dual permeation enhancers
US4764379A (en) 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US4879275A (en) 1987-09-30 1989-11-07 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agent
US4855294A (en) 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5332577A (en) 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5077284A (en) 1988-12-30 1991-12-31 Loria Roger M Use of dehydroepiandrosterone to improve immune response
DE3902013A1 (de) * 1989-01-25 1990-09-20 Knoll Ag Pflaster zur transdermalen anwendung
US5164416A (en) 1989-02-03 1992-11-17 Lintec Corporation Transdermal therapeutic formulation containing a limonene
US5053222A (en) * 1989-06-07 1991-10-01 Shiseido Company Ltd. Hair cosmetic composition
EP0480996A1 (de) * 1989-07-07 1992-04-22 Atrix Laboratories, Inc. Benzophenanthridin-alkaloide zur topischen aknetherapie
US5562910A (en) 1989-09-25 1996-10-08 University Of Utah Research Foundation Vaccine compositions and method for enhancing an immune response
US5096715A (en) 1989-11-20 1992-03-17 Alko Ltd. Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
US5324521A (en) 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
WO1991015241A1 (fr) 1990-03-30 1991-10-17 Yasunori Morimoto Composition absorbable par voie percutanee d'analgesiques narcotiques et non narcotiques .
DE4101515A1 (de) 1991-01-19 1992-07-23 Henkel Kgaa Ethersulfate fuer mund- und zahnpflegemittel
US5230897A (en) 1991-10-31 1993-07-27 G. D. Searle & Co. Transdermal pentamidine
US5460821A (en) 1993-06-23 1995-10-24 Masiz; John J. Molecular transdermal transport system
JP3599766B2 (ja) * 1993-12-01 2004-12-08 久光製薬株式会社 貼付製剤
WO1995031190A1 (en) * 1994-05-18 1995-11-23 Hisamitsu Pharmaceutical Co., Inc. Percutaneously administrable preparation for treating urination disorder
JPH0812519A (ja) * 1994-06-24 1996-01-16 Kao Corp 皮膚外用剤組成物
US5653970A (en) * 1994-12-08 1997-08-05 Lever Brothers Company, Division Of Conopco, Inc. Personal product compositions comprising heteroatom containing alkyl aldonamide compounds
US5529769A (en) * 1994-12-20 1996-06-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing betulinic acid
JP3533737B2 (ja) * 1994-12-21 2004-05-31 ライオン株式会社 生体老化防止剤及び皮膚用組成物
US5523090A (en) * 1995-02-24 1996-06-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin treatment composition
AU3440697A (en) * 1996-07-02 1998-01-21 Novartis Consumer Health S.A. Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds
CN1232389A (zh) * 1996-10-04 1999-10-20 崎玉第一制药株式会社 贴剂
US6019997A (en) * 1997-01-09 2000-02-01 Minnesota Mining And Manufacturing Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents

Also Published As

Publication number Publication date
ES2310042T3 (es) 2008-12-16
DE69939019D1 (de) 2008-08-14
AU4972599A (en) 2000-01-24
US6787152B2 (en) 2004-09-07
EP1094781B1 (de) 2008-07-02
PT1094781E (pt) 2008-10-08
JP2002519366A (ja) 2002-07-02
CA2336682C (en) 2006-10-10
DK1094781T3 (da) 2008-11-03
US7267829B2 (en) 2007-09-11
WO2000001351A1 (en) 2000-01-13
EP1094781A1 (de) 2001-05-02
US20030104040A1 (en) 2003-06-05
US20040202709A1 (en) 2004-10-14
MXPA00012844A (es) 2004-05-21
EP1094781A4 (de) 2007-01-17
CA2336682A1 (en) 2000-01-13
US6444234B1 (en) 2002-09-03

Similar Documents

Publication Publication Date Title
ATE399565T1 (de) Zusammensetzungen für die schnelle und nicht- irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung
BRPI0608249A2 (pt) formulação, método para aplicação tópica e kit para distribuição transdérmica de toxina botulìnica
ATE314092T1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
BRPI0416042A (pt) composição e aparelho para suprimento transdérmico
WO2004091521A3 (en) Methods and compositions for administration of trpv1 agonists
BR0311939A (pt) composição farmacêutica, método para tratar inflamação em um mamìfero e uso de uma citocina protetora de tecido orgánico
DE69727398D1 (de) Zusammensetzungen und verfahren zur topischen anwendungen von wirkstoffen
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
DE60329098D1 (de) Verwendung von mastix und dessen ätherischen ölen zur verhinderung oder bekämpfung von mikrobieller infektionen
BRPI0508410B8 (pt) composições e métodos para a aplicação tópica e liberação transdérmica de toxinas botulínicas
US8003696B2 (en) Composition and method for treating bacterial, viral, fungal diseases, inflammation and pain
CA2420895A1 (en) Method for treating erectile dysfunction and increasing libido in men
DE69428295D1 (de) Perkutane Behandlung mit Mastzelldegranulatoren zur Behandlung von Reizstoffüberempfindlichkeit
DE60114406D1 (de) Wirkstoffabgabesysteme zur behandlung von gefässerkrankungen
JP2010235471A (ja) 被膜形成型製剤
SA517390331B1 (ar) تراكيب مصفوفة بوليمر موضعية تشتمل على تركيز عالي من هيالورونات الصوديوم المخمر حيوياً واستخداماتها
DE60036915D1 (de) Verwendung von hyaluronan zur herstellung eines medikaments zur erhöhung der wirksamkeit von zytotoxischen arzneimitteln
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
BRPI0510760A (pt) método para administrar a um paciente uma composição, composição tópica, e, emplastro
SE9603725D0 (sv) New teatment
Papp et al. The safety and tolerability of topically delivered kynurenic acid in humans. A phase 1 randomized double-blind clinical trial
Meshulam et al. Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea‐pigs
BRPI0416870A (pt) composições anticáncer sinergìticas
ATE247965T1 (de) Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1094781

Country of ref document: EP